Lifecore Biomedical signs site-transfer agreement supporting pharma commercialization
Lifecore Biomedical (LFCR) signed an agreement for a commercial site transfer supporting a global pharmaceutical company’s tech transfer and commercial manufacturing of a currently marketed drug product.
Significant New Program Positioned to Become One of Lifecore’s Largest Contracts ---- Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Drug Product ---- Program Expected to Contribute to 2028 Commercial Revenues --CHASKA, Minn., Sept.
02, 2026 (GLOBE NEWSWIRE…